Squarepoint’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
MF
VI
FLAM
AAM
RSCM
Squarepoint's XENT Position: Q3 2021 in Review
Squarepoint sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 15,024 shares — an estimated $257K sold.
Squarepoint first reported a position in XENT in Q4 2015 and held it in 15 quarters. The position peaked at $1.48M in Q2 2018. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.
- Squarepoint reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
- Squarepoint sold 15,024 Intersect ENT, Inc shares in Q3 2021, an estimated $257K.
- Squarepoint first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 15 quarters.
- Squarepoint's Intersect ENT, Inc position peaked at $1.48M in Q2 2018.
- 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.
Based on Squarepoint's 13F filing for Q3 2021, filed 15 Nov 2021.